Literature DB >> 12623127

Peptide G protein agonists from a phage display library.

Jutta Hessling1, Martin J Lohse, Karl-Norbert Klotz.   

Abstract

G proteins may serve as targets for pharmacological activation of signaling pathways bypassing the regulatory events that may counteract the effect of the external stimulus on the level of receptors. We sought to identify peptides as lead structures interacting with G proteins utilizing a commercially available phage-display library. The heptapeptide library was screened for binding to human G alpha(i1) which was modified with a hexahistidine tag and immobilized on a Ni(2+)-coated surface. After several rounds of phage selection a number of phage clones with consensus sequences were found. Peptides with such sequences were chemically synthesized and their effect on [35S]GTP gamma S binding to G alpha(i1) and other G protein alpha subunits was determined. Through this process two peptide 'families' with the capability to activate G proteins were identified. The peptides showed no structural similarity to known peptide or nonpeptide G protein activators with a cationic amphiphilic structure like mastoparan or alkylamines. The functional relevance of the peptide-G protein interaction was shown by an increased sensitivity for guanine nucleotides of high-affinity agonist binding to A(1) adenosine receptors. The peptide G protein activators may, therefore, serve as novel tools for further investigation of receptor-independent activation of G proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623127     DOI: 10.1016/s0006-2952(02)01653-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  7 in total

1.  Structure of Galpha(i1) bound to a GDP-selective peptide provides insight into guanine nucleotide exchange.

Authors:  Christopher A Johnston; Francis S Willard; Mark R Jezyk; Zoey Fredericks; Erik T Bodor; Miller B Jones; Rainer Blaesius; Val J Watts; T Kendall Harden; John Sondek; J Kevin Ramer; David P Siderovski
Journal:  Structure       Date:  2005-07       Impact factor: 5.006

2.  Minimal determinants for binding activated G alpha from the structure of a G alpha(i1)-peptide dimer.

Authors:  Christopher A Johnston; Ekaterina S Lobanova; Alexander S Shavkunov; Justin Low; J Kevin Ramer; Rainer Blaesius; Zoey Fredericks; Francis S Willard; Brian Kuhlman; Vadim Y Arshavsky; David P Siderovski
Journal:  Biochemistry       Date:  2006-09-26       Impact factor: 3.162

Review 3.  State-selective binding peptides for heterotrimeric G-protein subunits: novel tools for investigating G-protein signaling dynamics.

Authors:  Christopher A Johnston; Francis S Willard; J Kevin Ramer; Rainer Blaesius; C Natalia Roques; David P Siderovski
Journal:  Comb Chem High Throughput Screen       Date:  2008-06       Impact factor: 1.339

Review 4.  Mechanistic pathways and biological roles for receptor-independent activators of G-protein signaling.

Authors:  Joe B Blumer; Alan V Smrcka; Stephen M Lanier
Journal:  Pharmacol Ther       Date:  2006-11-28       Impact factor: 12.310

5.  A bifunctional Galphai/Galphas modulatory peptide that attenuates adenylyl cyclase activity.

Authors:  Christopher A Johnston; J Kevin Ramer; Rainer Blaesius; Zoey Fredericks; Val J Watts; David P Siderovski
Journal:  FEBS Lett       Date:  2005-10-24       Impact factor: 4.124

6.  Advancement and applications of peptide phage display technology in biomedical science.

Authors:  Chien-Hsun Wu; I-Ju Liu; Ruei-Min Lu; Han-Chung Wu
Journal:  J Biomed Sci       Date:  2016-01-19       Impact factor: 8.410

Review 7.  Strategies towards Targeting Gαi/s Proteins: Scanning of Protein-Protein Interaction Sites To Overcome Inaccessibility.

Authors:  Britta Nubbemeyer; Anna Pepanian; Ajay Abisheck Paul George; Diana Imhof
Journal:  ChemMedChem       Date:  2021-03-22       Impact factor: 3.466

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.